Edition:
United Kingdom

Verastem Inc (VSTM.OQ)

VSTM.OQ on NASDAQ Stock Exchange Global Market

1.28USD
16 Aug 2019
Change (% chg)

$-0.01 (-0.78%)
Prev Close
$1.29
Open
$1.30
Day's High
$1.30
Day's Low
$1.28
Volume
95,722
Avg. Vol
434,138
52-wk High
$10.34
52-wk Low
$1.16

About

Verastem, Inc., is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the... (more)

Overall

Beta: 2.91
Market Cap(Mil.): $105.64
Shares Outstanding(Mil.): 73.88
Dividend: --
Yield (%): --

Financials

  VSTM.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.26 -- --
ROI: -66.70 7.52 12.69
ROE: -140.91 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates